drugset / Trial / NCT02467413

BAC in Patient With Alzheimer's Disease or Vascular Dementia

NCT02467413 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The primary objective of this study is to evaluate the efficacy of BAC patients with Alzheimer's disease or vascular dementia.The secondary objective of this study is to evaluate the safety of BAC patients with Alzheimer's disease or vascular dementia.

Timeline

Start
2017-01-30
Primary completion
2018-11-01
Completion
2018-11-01

Outcome

Outcome not reported

Stopped (Enrollment): “The study was withdrawn before participants were enrolled.”

Drugs

EvaluationDrugModalityDoseRoute
Comparator BAC Unknown 30 g Topical